These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35165042)

  • 21. Pharmacy students' knowledge, attitudes, and evaluation of direct-to-consumer advertising.
    Naik RK; Borrego ME; Gupchup GV; Dodd M; Sather MR
    Am J Pharm Educ; 2007 Oct; 71(5):86. PubMed ID: 17998983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs.
    Faerber AE; Kreling DH
    J Gen Intern Med; 2014 Jan; 29(1):110-8. PubMed ID: 24030427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 'At-risk' individuals' responses to direct to consumer advertising of prescription drugs: a nationally representative cross-sectional study.
    Khalil Zadeh N; Robertson K; Green JA
    BMJ Open; 2017 Dec; 7(12):e017865. PubMed ID: 29217723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consumers' experience with and attitudes toward direct-to-consumer prescription drug promotion: a nationally representative survey.
    Aikin KJ; Sullivan HW; Berktold J; Stein KL; Hoverman VJ
    Health Mark Q; 2021; 38(1):1-11. PubMed ID: 34238134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consumer perceptions of prescription and over-the-counter drug advertisements with promotional offers.
    Aikin KJ; Sullivan HW; O'Donoghue AC; Betts KR
    Health Mark Q; 2016; 33(4):291-306. PubMed ID: 27841741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Who are the opinion leaders? The physicians, pharmacists, patients, and direct-to-consumer prescription drug advertising.
    Lee AL
    J Health Commun; 2010 Sep; 15(6):629-55. PubMed ID: 20812124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Strategies to foster an adequate compromise of the pharmacist with respect to over the counter medicines’ advertisement.].
    Armando PD; Tenllado MI; Martínez P; Uema SA
    Rev Fac Cien Med Univ Nac Cordoba; 2018 Nov; 75(4):234-239. PubMed ID: 30734701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall.
    O'Donoghue AC; Williams PA; Sullivan HW; Boudewyns V; Squire C; Willoughby JF
    Soc Sci Med; 2014 Nov; 120():1-11. PubMed ID: 25194471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of use, comprehensibility and clarity of over-the-counter medicine labels: Consumers' perspectives and needs in Taiwan.
    Huang YM; Chen LJ; Hsieh LL; Chan HY; Chen-Liu KCS; Ho YF
    Health Soc Care Community; 2022 Feb; 30(2):753-761. PubMed ID: 33034423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OTC drug advertising in Japan: the role of need for cognition and celebrity endorser credibility.
    Morimoto M
    Health Mark Q; 2020; 37(2):108-123. PubMed ID: 32208968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consumers' Perceptions About Pharmaceutical Care Provided by Community Pharmacists in China in Relation to Over-the-Counter Drugs: A Qualitative Study.
    Chen H; Ung COL; Chi P; Wu J; Tang D; Hu H
    Inquiry; 2018; 55():46958018793292. PubMed ID: 30095016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy.
    Mintzes B; Barer M; Lexchin J; Bassett KL
    Res Social Adm Pharm; 2005 Jun; 1(2):310-30. PubMed ID: 17138480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Australian consumer responses to DTCA and other pharmaceutical company sponsored advertisements.
    Hall DV; Jones SC
    Aust N Z J Public Health; 2008 Oct; 32(5):471-8. PubMed ID: 18959553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease-specific direct-to-consumer advertising of pharmaceuticals: An examination of endorser type and gender effects on consumers' attitudes and behaviors.
    Bhutada NS; Rollins BL
    Res Social Adm Pharm; 2015; 11(6):891-900. PubMed ID: 25797861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. User testing as a method for identifying how consumers say they would act on information related to over-the-counter medicines.
    Tong V; Raynor DK; Aslani P
    Res Social Adm Pharm; 2017; 13(3):476-484. PubMed ID: 27423784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Animated Spokes-Characters in Print Direct-to-Consumer Prescription Drug Advertising: An Elaboration Likelihood Model Approach.
    Bhutada NS; Rollins BL; Perri M
    Health Commun; 2017 Apr; 32(4):391-400. PubMed ID: 27315337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
    Kim H
    Int J Health Policy Manag; 2015 Aug; 4(12):813-21. PubMed ID: 26673465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient experiences of over-the-counter medicine purchases in Flemish community pharmacies.
    Simoens S; Lobeau M; Verbeke K; van Aerschot A
    Pharm World Sci; 2009 Aug; 31(4):450-457. PubMed ID: 19333777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Media credibility and informativeness of direct-to-consumer prescription drug advertising.
    Huh J; DeLorme DE; Reid LN
    Health Mark Q; 2004; 21(3):27-61. PubMed ID: 15739826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Issues related to monitoring the safety of over-the-counter (OTC) medicines.
    Bond C; Hannaford P
    Drug Saf; 2003; 26(15):1065-74. PubMed ID: 14640771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.